Quoin Pharmaceuticals (QNRX)

• Market cap: $12.8M
• 1 day: -3.87%
• 5 days: 0.63%
• 1 month: -7.78%
• 3 months: -42.25%
• 6 months: 13.27%
• Year to date: -43.61%
• 1 year: -21.77%
• 5 years: -99.99%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3